₹1980*
MRP ₹2200
10% off
₹1870*
MRP ₹2200
15% CB
₹330 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
उपभोग प्रकार :
वापसी नीति :
को या उसके बाद समाप्त हो जाएगा :
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Co-administration of Cidofovir and Zoledac 4 mg Injection 5 ml can increase the risk of kidney problems.
How to manage the interaction:
Taking Cidofovir and Zoledac 4 mg Injection 5 ml together is not recommended as it can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Zoledac 4 mg Injection 5 ml and Tenofovir alafenamide can increase the risk of kidney problems.
How to manage the interaction:
Taking Zoledac 4 mg Injection 5 ml and Tenofovir alafenamide together can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Sirolimus and Zoledac 4 mg Injection 5 ml can increase the risk or severity of kidney problems.
How to manage the interaction:
Taking Sirolimus and Zoledac 4 mg Injection 5 ml together can lead to an interaction, but it can be taken if a doctor advises. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Zoledac 4 mg Injection 5 ml (oral form) with Deferasirox can increase the risk of bleeding and ulcers in the stomach and intestines.
How to manage the interaction:
Although taking Zoledac 4 mg Injection 5 ml and Deferasirox together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, or irregular heart rhythm, seek immediate medical attention. Drink plenty of water if you experience diarrhoea or vomiting while taking these medications, as dehydration can potentially affect the kidneys. Do not discontinue any medications without a doctor's advice.
Taking Tacrolimus with Zoledac 4 mg Injection 5 ml may increase risk of kidney problems.
How to manage the interaction:
Although taking Tacrolimus and Zoledac 4 mg Injection 5 ml together can possibly result in an interaction, it can be taken if a doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of hunger, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
Co-administration of Human immunoglobulin with Zoledac 4 mg Injection 5 ml, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Zoledac 4 mg Injection 5 ml, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
Caution
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली के साथ शराब का सेवन करने से होने वाली प्रतिक्रिया अज्ञात है। कृपया ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली के साथ शराब का सेवन करने से पहले डॉक्टर से परामर्श लें।
गर्भावस्था
Unsafe
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली एक श्रेणी डी गर्भावस्था दवा है और गर्भवती महिलाओं के लिए अनुशंसित नहीं है क्योंकि यह अजन्मे बच्चे को नुकसान पहुंचा सकती है। यदि आप गर्भवती हैं तो कृपया डॉक्टर से परामर्श लें।
स्तनपान
Unsafe
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली स्तनपान कराने वाली माताओं के लिए निषिद्ध है। इसलिए, यदि आप स्तनपान करा रही हैं तो कृपया डॉक्टर से परामर्श लें।
ड्राइविंग
Caution
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली के सेवन से चक्कर आ सकते हैं। इसलिए, अगर आपको ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली लेने के बाद चक्कर आ रहे हैं, तो गाड़ी चलाने या मशीनरी चलाने से बचें।
जिगर
Caution
सावधानी के साथ ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली लें, खासकर अगर आपको लिवर की बीमारियों/स्थितियों का इतिहास है। आपके डॉक्टर द्वारा आवश्यकतानुसार खुराक को समायोजित किया जा सकता है।
किडनी
Caution
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली को सावधानी से लें, खासकर अगर आपको किडनी की बीमारियों/स्थितियों का इतिहास है। खुराक को आपके डॉक्टर द्वारा आवश्यकतानुसार समायोजित किया जा सकता है। अगर आपको किडनी की गंभीर समस्या है तो ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली को लेने से बचें।
बच्चे
Unsafe
ज़ोलेडैक 4 मिलीग्राम इंजेक्शन 5 मिली की सिफारिश 18 वर्ष से कम उम्र के बच्चों के लिए नहीं की जाती है क्योंकि इसकी सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Have a query?
Disclaimer
Author Details
